Belong.life, a global leader in AI-powered patient engagement platforms, announced a strategic partnership with Equiva, a U.S.-based digital health company serving hundreds of medical facilities in both acute and post-acute settings.
As part of this partnership, Equiva will integrate Belong's validated conversational AI mentors -starting with Dave, a trusted expert in cancer care,...
Gestalt, a leading innovator in AI-powered digital pathology solutions, announced the completion of a $7.5 million Series A financing. The round was led by Cowles Ventures, TVF Funds, Inland Imaging Investments, KickStart Funds, and prominent angel investors from the Pacific Northwest.
Gestalt's PathFlow platform is used by leading healthcare, academic medical centers, and...
PACS fuels faster, more precise diagnosis and patient triaging for busy healthcare providers to assist with decision-making
CliniComp, the pioneer in high-performing, reliable electronic health record (EHR) solutions, announced the addition of Picture Archiving and Communication System (PACS) to its New Era EHR with Intrinsic AI™ Solution Suite.
Their enterprise-wide PACS...
Collaboration will deliver innovative AI-powered pathology tools and quality control enhancements to accelerate clinical trials and biomarker discovery
Precision for Medicine, a leading provider of next generation drug development research and services, and PathAI, a global leader in digital pathology, announced a strategic collaboration to partner on developing novel AI-based...
Clinical ink, a global leader in life science technology, announced the launch of TrialLens™, a fully integrated, AI-powered analytics dashboard that transforms how clinical trial eCOA data is visualized, queried, and interpreted. TrialLens delivers real-time, actionable insights into study operations, participant behavior, and digital biomarker metrics across decentralized and...
Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analytics, announced the successful closing of its seed funding round. It raised $7.2 million in new equity investments and converted $4.0 million into SAFEs, bringing the total funding raised since Araceli's spin-off from Phoseon Technology to $11.2 million....
Axtria InsightsMAx.ai Delivers an Enterprise-Grade Flexible Framework with 30+ Ready-to-Deploy Agents, Apps, and APIs
Axtria Inc., an AI-first data analytics innovator transforming life sciences, announced its next generation of Axtria InsightsMAx™. Powered by agentic AI, the new Axtria InsightsMAx.ai fundamentally reimagines how life sciences organizations harness artificial intelligence through a flexible...
SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce their partnership with Lunit, a global leader in AI-driven cancer diagnostics and therapeutics, to bring a new era of AI-powered breast cancer detection to patients across the country. The...
Healthee, the AI-powered platform transforming the health benefits experience, announced a $50 million Series B funding round led by Key1 Capital, with continued backing from Fin Capital, Glilot Capital Partners, and Group11.
Healthee did not formally launch this raise. Key1 Capital approached the team after tracking the company's traction, believing in...
Robust preclinical pipeline of non-hallucinogenic neuroplastogens designed as potential best-in-class treatments for neuropsychiatric and neurodegenerative diseases
Transneural Therapeutics, Inc. (Transneural), a preclinical-stage biotechnology company aiming to transform the treatment of neuropsychiatric and neurodegenerative diseases with novel neuroplastogens, announced its launch now. Transneural was founded to address the high unmet need...
